Aurobindo Pharma announces ₹800 Cr buyback of 5.42M shares at ₹1,475/share

Aurobindo Pharma Ltd has submitted the Letter of Offer for its buyback program, aiming to repurchase up to 5,423,728 fully paid-up equity shares. This represents approximately 0.93% of the company's total outstanding equity shares. The buyback price is fixed at ₹1,475 per equity share, payable in cash, for an aggregate amount of up to ₹800 crore, excluding transaction costs. The buyback will be conducted through a tender offer route on a proportionate basis. The Record Date for determining eligible shareholders was April 17, 2026. The buyback offer will open on April 23, 2026, and close on April 29, 2026. The Letter of Offer was e-mailed to eligible shareholders on April 21, 2026.